Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Focal vibration in neurorehabilitation.
Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months.
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis.
Treatment of multiple sclerosis with the pregnancy hormone estriol.
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients.
A much-needed focus on progression in multiple sclerosis.
Once-daily AUBAGIO® delayed onset of clinically definite multiple sclerosis (MS) in TOPIC study
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects.
Are natural killer cells involved in multiple sclerosis etiology? Evidences from NKp46/NCR1 receptor modulation in an observational study.
Astrocyte-derived lactosylceramide implicated in multiple sclerosis.
The brain antigen-specific B cell response correlates with glatiramer acetate responsiveness in relapsing-remitting multiple sclerosis patients.
Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events.
Treatments for relapsing-remitting multiple sclerosis: summarising current information by network meta-analysis.
Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.
A longitudinal uncontrolled study of cerebral gray matter volume in patients receiving natalizumab for multiple sclerosis.
Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.
A robust type I interferon gene signature from blood RNA defines quantitative but not qualitative differences between three major IFNβ drugs in the treatment of multiple sclerosis.
Interferon in relapsing-remitting multiple sclerosis.
Effect of disease-modifying therapies on brain volume in relapsing-remitting multiple sclerosis: results of a five-year brain MRI study.
Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy.
Gpr126 is essential for peripheral nerve development and myelination in mammals.
Antioxidant properties of the triaminopyridine, flupirtine.
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
Receptos doses first patient in Phase 2/3 trial for RPC1063 in multiple sclerosis
FTY720 impairs CD8 T-cell function independently of the sphingosine-1-phosphate pathway.

Pages